Search results
Results from the WOW.Com Content Network
A disease-modifying osteoarthritis drug (DMOAD) is a disease-modifying drug that would inhibit or even reverse the progression of osteoarthritis. [1] Since the main hallmark of osteoarthritis is cartilage loss, a typical DMOAD would prevent the loss of cartilage and potentially regenerate it.
[citation needed] More recently, the term has been used to indicate a drug that reduces the rate of damage to bone and cartilage. [ citation needed ] DMARDs can be further subdivided into traditional small molecular mass drugs synthesised chemically and newer "biological" agents produced through genetic engineering.
Bone tissue is removed by osteoclasts, and then new bone tissue is formed by osteoblasts. Both processes utilize cytokine (TGF-β, IGF) signalling.In osteology, bone remodeling or bone metabolism is a lifelong process where mature bone tissue is removed from the skeleton (a process called bone resorption) and new bone tissue is formed (a process called ossification or new bone formation).
Biological response modifiers (BRMs) are substances that modify immune responses. They can be endogenous (produced naturally within the body) or exogenous (as pharmaceutical drugs ), and they can either enhance an immune response or suppress it .
Surface modification is the act of modifying the surface of a material by bringing physical, chemical or biological characteristics different from the ones originally found on the surface of a material. [1] This modification is usually made to solid materials, but it is possible to find examples of the modification to the surface of specific ...
Kelley denied raping the teen when FBI agents visited him at the college in April 2023, prosecutors said. But after the feds arrested him at the university in September 2023, a student came ...
The NBA and commissioner Adam Silver were eager to make changes to the All-Star Game after last year's contest wasn't very competitive and finished with a final score of 211-186.
“For the first time in over a year,” said Laurie Schalow, Chipotle's chief corporate affairs officer, “We have taken a modest price increase of approximately 2% nationally to offset inflation."